Affimed (AFMD) Reports Preclinical Data on Mechanism of Action of two Innate Cell Engagers, Demonstrating their Potential to Induce Antibody Dependent Cellular Phagocytosis and Serial Killing
Go back to Affimed (AFMD) Reports Preclinical Data on Mechanism of Action of two Innate Cell Engagers, Demonstrating their Potential to Induce Antibody Dependent Cellular Phagocytosis and Serial Killing| (NASDAQ: AFMD) | Delayed: 0.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.18 | 52 Week High | $8.26 | |||
| Open | $0.18 | 52 Week Low | $1.75 | |||
| Day High | $0.18 | P/E | N/A | |||
| Day Low | $0.18 | EPS | $0.00 | |||
| Volume | 1,822 | |||||
